Evidence map›Paper›PMID 30619251›Full record

ArticleFrontiers in immunology2018

Cardioprotection of Ginkgolide B on Myocardial Ischemia/Reperfusion-Induced Inflammatory Injury via Regulation of A20-NF-κB Pathway.

Rui Zhang, Lin Xu, Dong Zhang, Bo Hu, Qi Luo, Dan Han, Jiangbing Li, Chengwu Shen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Acta pharmaceutica Sinica. B · 2024
    Review
  12. Article
  13. Article
  14. Antioxidants (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rui ZhangDepartment of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Lin XuDepartment of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Dong ZhangDepartment of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Bo HuMinimally Invasive Urology Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Qi LuoDepartment of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Dan HanDepartment of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Jiangbing LiDepartment of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Chengwu ShenDepartment of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Shandong University · CNShandong Provincial Hospital · CNNanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation urges most of the characteristics of plaques involved in the pathogenesis of myocardial ischemia/reperfusion injury (MI/RI). In addition, inflammatory signaling pathways not only mediate the properties of plaques that precipitate ischemia/reperfusion (I/R) but also influence the clinical consequences of the post-infarction remodeling and heart failure. Here, we studied whether Ginkgolide B (GB), an effective anti-inflammatory monomer, improved MI/RI via suppression of inflammation. Left anterior descending (LAD) coronary artery induced ischemia/reperfusion (I/R) of rats or A20 silencing mice, as well as hypoxia/reoxygenation (H/R) induced damages of primary cultured rat neonatal ventricular myocytes or A20 silencing ventricular myocytes, respectively, served as MI/RI model

Indexed as

Myocardial Reperfusion InjuryAnimalsCardiotonic AgentsDisease Models, AnimalDNA-Binding ProteinsGinkgolidesLactonesMaleRatsRats, Sprague-DawleySignal TransductionTranscription Factor RelATumor Necrosis Factor alpha-Induced Protein 3Cardiotonic AgentsDNA-Binding Proteinsginkgolide BGinkgolidesLactonesRela protein, ratTNFAIP3 protein, ratTranscription Factor RelATumor Necrosis Factor alpha-Induced Protein 3A20Ginkgolide BInflammationMyocardial ischemia/reperfusion injuryNF-κB

Identifiers

PMID30619251
PMCPMC6299132
OpenAlexW2904957166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.